Cargando…
BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
Background: Lung adenocarcinoma (LUAD) is the most prevalent thoracic cancer with the highest incidence and mortality worldwide. Baculoviral IAP Repeat Containing 5 (BIRC5) is well studied in many malignancies, its prognosis value and correlation with the tumor microenvironment (TME) in LAUD remains...
Autores principales: | Ma, Teng, Gu, Jie, Wen, Haoyu, Xu, Fengkai, Ge, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414029/ https://www.ncbi.nlm.nih.gov/pubmed/36046648 http://dx.doi.org/10.7150/jca.69236 |
Ejemplares similares
-
BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
por: Xu, Linlong, et al.
Publicado: (2021) -
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021) -
PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022) -
Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
por: Tong, Ling, et al.
Publicado: (2022) -
Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
por: Noh, Byeong-Joo, et al.
Publicado: (2020)